GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Transgene SA (XPAR:TNG) » Definitions » Other Current Payables

Transgene (XPAR:TNG) Other Current Payables : €0.09 Mil (As of Dec. 2023)


View and export this data going back to 1998. Start your Free Trial

What is Transgene Other Current Payables?

Transgene's Other Current Payables for the quarter that ended in Dec. 2023 was €0.09 Mil.

Transgene's quarterly Other Current Payables stayed the same from Dec. 2022 (€0.00 Mil) to Jun. 2023 (€0.00 Mil) but then increased from Jun. 2023 (€0.00 Mil) to Dec. 2023 (€0.09 Mil).

Transgene's annual Other Current Payables increased from Dec. 2021 (€-0.00 Mil) to Dec. 2022 (€0.00 Mil) and increased from Dec. 2022 (€0.00 Mil) to Dec. 2023 (€0.09 Mil).


Transgene Other Current Payables Historical Data

The historical data trend for Transgene's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Transgene Other Current Payables Chart

Transgene Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.09

Transgene Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 0.09

Transgene Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.


Transgene Other Current Payables Related Terms

Thank you for viewing the detailed overview of Transgene's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.


Transgene (XPAR:TNG) Business Description

Traded in Other Exchanges
Address
400 Boulevard Gonthier d’Andernach, Parc d’Innovation - CS80166, Illkirch-Graffenstaden, FRA, 67400
Transgene SA is a biotechnology company. It is involved in the business of discovering and focusing immune-targeted therapies for the treatment of cancer and infectious diseases. The company's clinical-stage programs are TG4010 for non-small cell lung cancer and Pexa-vec for liver cancer. Its product pipeline includes TG4001, TG1050, TG6002 etc. It is engaged in clinical research and development of therapeutic vaccines and immunotherapeutic products.

Transgene (XPAR:TNG) Headlines

No Headlines